换一批Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer: a collaborative analysis of 20 prospective studies and Mendelian randomization analysis.
第一作者：
Eleanor L,Watts
第一单位：
Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
作者：
Eleanor L,Watts [1]
;
Aurora,Perez-Cornago [1]
;
Georgina K,Fensom [1]
;
Karl,Smith-Byrne [2]
;
Urwah,Noor [1]
;
Colm D,Andrews [1]
;
Marc J,Gunter [3]
;
Michael V,Holmes [4]
;
Richard M,Martin [5]
;
Konstantinos K,Tsilidis [6]
;
Demetrius,Albanes [7]
;
Aurelio,Barricarte [8]
;
H Bas,Bueno-de-Mesquita [9]
;
Barbara A,Cohn [10]
;
Melanie,Deschasaux-Tanguy [11]
;
Niki L,Dimou [3]
;
Luigi,Ferrucci [12]
;
Leon,Flicker [13]
;
Neal D,Freedman [7]
;
Graham G,Giles [14]
;
Edward L,Giovannucci [15]
;
Christopher A,Haiman [16]
;
Graham J,Hankey [17]
;
Jeffrey M P,Holly [18]
;
Jiaqi,Huang [19]
;
Wen-Yi,Huang [7]
;
Lauren M,Hurwitz [7]
;
Rudolf,Kaaks [20]
;
Tatsuhiko,Kubo [21]
;
Loic,Le Marchand [22]
;
Robert J,MacInnis [23]
;
Satu,Männistö [24]
;
E Jeffrey,Metter [25]
;
Kazuya,Mikami [26]
;
Lorelei A,Mucci [27]
;
Anja W,Olsen [28]
;
Kotaro,Ozasa [29]
;
Domenico,Palli [30]
;
Kathryn L,Penney [31]
;
Elizabeth A,Platz [32]
;
Michael N,Pollak [33]
;
Monique J,Roobol [34]
;
Catherine A,Schaefer [35]
;
Jeannette M,Schenk [36]
;
Pär,Stattin [37]
;
Akiko,Tamakoshi [38]
;
Elin,Thysell [39]
;
Chiaojung Jillian,Tsai [40]
;
Mathilde,Touvier [11]
;
Stephen K,Van Den Eeden [41]
;
Elisabete,Weiderpass [42]
;
Stephanie J,Weinstein [7]
;
Lynne R,Wilkens [22]
;
Bu B,Yeap [43]
;
PRACTICAL Consortium, CRUK, BPC3, CAPS, PEGASUS [44]
;
Naomi E,Allen [1]
;
Timothy J,Key [1]
;
Ruth C,Travis
作者单位：
Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
[1]
Genomic Epidemiology Branch, International Agency for Research on Cancer, Lyon, France.
[2]
Section of Nutrition and Metabolism, International Agency for Research on Cancer, Lyon, France.
[3]
Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford, UK.;Medical Research Council Population Health Research Unit, University of Oxford, Oxford, UK.
[4]
Department of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.;MRC Integrative Epidemiology Unit (IEU), Bristol Medical School, University of Bristol, Bristol, UK.;National Institute for Health Research (NIHR) Bristol Biomedical Research Centre, University Hospitals Bristol NHS Foundation Trust and Weston NHS Foundation Trust and University of Bristol, Bristol, UK.
[5]
Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.;Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece.
[6]
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
[7]
Group of Epidemiology of Cancer and Other Chronic Diseases, Navarra Public Health Institute, Pamplona, Spain.;Group of Epidemiology of Cancer and Other Chronic Diseases, Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.;CIBER Epidemiology and Public Health CIBERESP, Madrid, Spain.
[8]
Centre for Nutrition, Prevention and Health Services, National Institute for Public Health and the Environment (RIVM), Utrecht, The Netherlands.
[9]
Child Health and Development Studies, Public Health Institute, Berkeley, CA, USA.
[10]
Sorbonne Paris Nord University, Nutritional Epidemiology Research Team, Epidemiology and Statistics Research Center, University of Paris, Bobigny, France.
[11]
National Institute on Aging, Baltimore, MD, USA.
[12]
WA Centre for Health & Ageing, Medical School, University of Western Australia, Perth, WA, Australia.;Western Australian Centre for Health and Ageing, University of Western Australia, Perth, WA, Australia.
[13]
Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, VIC, Australia.;Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, VIC, Australia.;Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Melbourne, VIC, Australia.
[14]
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.;Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.;Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
[15]
Department of Preventive Medicine, Center for Genetic Epidemiology, Keck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, CA, USA.
[16]
WA Centre for Health & Ageing, Medical School, University of Western Australia, Perth, WA, Australia.
[17]
IGFs & Metabolic Endocrinology Group, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
[18]
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.;National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education, and Department of Metabolism and Endocrinology, Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
[19]
Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
[20]
Department of Public Health and Health Policy, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
[21]
University of Hawaii, Cancer Center, Honolulu, HI, USA.
[22]
Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, VIC, Australia.;Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Melbourne, VIC, Australia.
[23]
Department of Public Health and Welfare, Finnish Institute for Health and Welfare, Helsinki, Finland.
[24]
Department of Neurology, College of Medicine, University of Tennessee Health Science Center, Memphis, TN, USA.
[25]
Departmemt of Urology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan.
[26]
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
[27]
Department of Public Health, Aarhus University, Aarhus, Denmark.;Danish Cancer Society, Research Center, Copenhagen, Denmark.
[28]
Departmemt of Epidemiology, Radiation Effects Research Foundation, Hiroshima, Japan.
[29]
Cancer Risk Factors and Life-Style Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network, Florence, Italy.
[30]
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.;Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
[31]
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
[32]
Departments of Medicine and Oncology, McGill University, Montreal, QC, Canada.
[33]
Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands.
[34]
Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA.
[35]
Cancer Prevention Program, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
[36]
Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
[37]
Department of Public Health, Faculty of Medicine, Hokkaido University, Sapporo, Japan.
[38]
Department of Medical Biosciences, Umeå University, Umeå, Sweden.
[39]
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
[40]
Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA.;Department of Urology, University of California San Francisco, San Francisco, CA, USA.
[41]
Director's Office, International Agency for Research on Cancer, World Health Organization, Lyon, France.
[42]
WA Centre for Health & Ageing, Medical School, University of Western Australia, Perth, WA, Australia.;Department of Endocrinology and Diabetes, Fiona Stanley Hospital, Perth, WA, Australia.
[43]
Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford, UK.;UK Biobank Ltd, Stockport, UK.
[44]
主题词
男(雄)性(Male);人类(Humans);胰岛素样生长因子Ⅰ(Insulin-Like Growth Factor I);胰岛素样生长因子Ⅱ(Insulin-Like Growth Factor II);胰岛素样生长因子结合蛋白质3(Insulin-Like Growth Factor Binding Protein 3);胰岛素样生长因子结合蛋白质1(Insulin-Like Growth Factor Binding Protein 1);前瞻性研究(Prospective Studies);孟德尔随机化分析(Mendelian Randomization Analysis);前列腺肿瘤(Prostatic Neoplasms);危险因素(Risk Factors);病例对照研究(Case-Control Studies)
DOI
10.1093/ije/dyac124
PMID
35726641
发布时间
2024-11-30
- 浏览2
International journal of epidemiology
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
